West to Participate in Upcoming Investor Conferences
West Pharmaceutical Services (NYSE: WST), a leading provider of injectable drug administration solutions, has announced its participation in two upcoming investor conferences. The company will present at the BofA Securities Annual Healthcare Conference on May 14, 2025, at 2:20 PM PT, and at the William Blair 45th Annual Growth Stock Conference on June 5, 2025, at 10:40 AM CT. Live audio webcasts will be accessible through the company's website's "Investors" section, with replays available for approximately 90 days following the events.
West Pharmaceutical Services (NYSE: WST), un fornitore leader di soluzioni per la somministrazione di farmaci iniettabili, ha annunciato la sua partecipazione a due prossimi incontri con investitori. L'azienda presenterà al BofA Securities Annual Healthcare Conference il 14 maggio 2025 alle 14:20 PT, e al William Blair 45th Annual Growth Stock Conference il 5 giugno 2025 alle 10:40 CT. Le trasmissioni audio in diretta saranno disponibili nella sezione "Investitori" del sito web aziendale, con repliche accessibili per circa 90 giorni dopo gli eventi.
West Pharmaceutical Services (NYSE: WST), un proveedor líder de soluciones para la administración de medicamentos inyectables, ha anunciado su participación en dos próximas conferencias para inversores. La compañía presentará en la BofA Securities Annual Healthcare Conference el 14 de mayo de 2025 a las 2:20 PM PT, y en la William Blair 45th Annual Growth Stock Conference el 5 de junio de 2025 a las 10:40 AM CT. Las transmisiones de audio en vivo estarán disponibles en la sección "Inversores" del sitio web de la compañía, con repeticiones accesibles durante aproximadamente 90 días después de los eventos.
West Pharmaceutical Services (NYSE: WST)는 주사제 투여 솔루션의 선도 기업으로, 다가오는 두 개의 투자자 컨퍼런스에 참여할 예정임을 발표했습니다. 회사는 2025년 5월 14일 오후 2시 20분(태평양 시간)에 BofA Securities Annual Healthcare Conference에서, 2025년 6월 5일 오전 10시 40분(중부 시간)에 William Blair 45th Annual Growth Stock Conference에서 발표를 진행할 예정입니다. 생중계 오디오 웹캐스트는 회사 웹사이트의 "투자자" 섹션을 통해 제공되며, 행사 후 약 90일간 다시보기 서비스도 이용할 수 있습니다.
West Pharmaceutical Services (NYSE : WST), un fournisseur de premier plan de solutions pour l'administration de médicaments injectables, a annoncé sa participation à deux prochaines conférences pour investisseurs. La société présentera lors de la BofA Securities Annual Healthcare Conference le 14 mai 2025 à 14h20 PT, ainsi qu'à la William Blair 45th Annual Growth Stock Conference le 5 juin 2025 à 10h40 CT. Les webcasts audio en direct seront accessibles via la section "Investisseurs" du site internet de la société, avec des rediffusions disponibles pendant environ 90 jours après les événements.
West Pharmaceutical Services (NYSE: WST), ein führender Anbieter von Lösungen für die Verabreichung injizierbarer Medikamente, hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen angekündigt. Das Unternehmen wird am BofA Securities Annual Healthcare Conference am 14. Mai 2025 um 14:20 Uhr PT und am William Blair 45th Annual Growth Stock Conference am 5. Juni 2025 um 10:40 Uhr CT präsentieren. Live-Audio-Webcasts sind über den Bereich "Investoren" auf der Unternehmenswebsite verfügbar, mit Wiedergaben, die etwa 90 Tage nach den Veranstaltungen abrufbar sind.
- None.
- None.
It will also present at the William Blair 45th Annual Growth Stock Conference on Thursday, June 5, 2025 at 10:40 AM CT.
A live audio webcast of these events will be available in the "Investors" section of the Company's website at www.westpharma.com. Replay of the webcasts will be available for approximately 90 days after the events.
About West
West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With over 10,000 team members across 50 sites including 25 manufacturing facilities worldwide, West helps support our customers by delivering over 41 billion components and devices each year.
Headquartered in
All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted.
View original content to download multimedia:https://www.prnewswire.com/news-releases/west-to-participate-in-upcoming-investor-conferences-302449075.html
SOURCE West Pharmaceutical Services, Inc.